Loading
Latest filing published 04 Jun 2026 for Oncolytics Biotech Inc., €171k. Read the official filing
No signal scores available.
One trade, one date: on 4 June 2026, Allison Hagerman disclosed an option exercise of €171k in Oncolytics Biotech Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration